We have previously shown that activated gd T cells have a much stronger proinflammatory effect in the development of experimental autoimmune uveitis than their nonactivated counterparts. Our present study explored gd T cell subsets are functionally distinct in autoimmune pathogenesis and determined the pathogenic contribution of biased Vg4 + gd T cell activation in this disease. By systematically comparing two major peripheral gd T cell subsets, the Vg1 + and the Vg4 + cells, we found that the Vg4 + cells were readily activated in B6 mice during experimental autoimmune uveitis development, whereas Vg1 + cells remained nonactivated. Cytokines that were abundantly found in the serum of immunized mice activated Vg4 + , but did not activate Vg1 + , cells. The Vg4 + cells had a strong proinflammatory activity, whereas the Vg1 + cells remained nonactivated when tested immediately after isolation from immunized mice. However, when the Vg1 + cells were activated in vitro, they promoted inflammation.
Our results demonstrated that activation is a major factor in switching the enhancing and inhibiting effects of both Vg1 + and Vg4 + gd T cell subsets, and that gd T cell subsets differ greatly in their activation requirements. Whether the enhancing or inhibiting function of gd T cells is dominant is mainly determined by the proportion of the gd T cells that are activated versus the proportion not activated. The Journal of Immunology, 2017, 198: 000-000.
T he gd T cells play a major role in both innate and adaptive immunity (1, 2) and are the early infiltrating cells in inflammatory disorders such as autoimmune diseases (3) (4) (5) (6) (7) (8) (9) (10) . Studies have shown that gd T cells can either enhance (9, (11) (12) (13) (14) (15) or inhibit (8, (15) (16) (17) (18) (19) (20) an adaptive immune response. This functional diversity has been previously credited to gd T cell subsets that express distinct TCRs (21) (22) (23) (24) (25) . Later studies have also demonstrated that the enhancing and inhibiting activities of gd T cells could be reversed if gd T cells were pre-exposed to bacterial products (23, 25) . Clinical approaches have been developed to use gd T cells as a therapeutic modality (26) (27) (28) . A better knowledge of how these cells exert their enhancing and inhibitory functions should improve their therapeutic use.
More than 90% of the gd T cells in the peripheral lymphoid tissues of naive mouse are either Vg1 + or Vg4 + gd T cells; among these, Vg1 + gd T cells are the major components (29) . This dominance shifts during disease. Thus, at the peak of the peripheral immune response in induced autoimmune diseases such as experimental autoimmune encephalomyelitis and autoimmune uveitis (EAU), the dominant Vg1 + gd T cells are rapidly replaced by Vg4 + gd T cells; meanwhile, the total gd T cell number is increased by 5-to 10-fold (11, (30) (31) (32) (33) . We have previously shown that activated gd T cells have a much stronger proinflammatory effect than their nonactivated counterparts (34) (35) (36) . Studies on the mechanism of how gd T cells become activated and whether manipulation of gd activation could allow us to control disease progression should have implications for their therapeutic use.
Using a mouse EAU model that consistently demonstrated a dominant activation of Vg4 + gd T cells in a preclinical stage (30), we investigated the mechanism leading to this biased gd activation and the correlation of disease pathogenesis and the dominance shift. Our results showed that activation of macrophages/dendritic cells (DCs) in the immunized mice produces increased amounts of cytokines; these cytokines have a biased stimulatory effect on Vg4 + cells, but not on Vg1 + cells, leading to a preferential activation and expansion of the Vg4 + gd subset. Structural and functional comparison between Vg1 + and Vg4 + gd T cell subsets isolated from EAU-prone B6 mice before or after immunization showed that the enhancing and inhibitory functions of both Vg1 + and Vg4 + T cells are determined by their activation status. The Vg4 + cells are dominant among the activated gd T cells in immunized mice, and these cells possessed greatly increased proinflammatory activity. By contrast, the Vg1 + cells remained nonactivated in immunized mice and are functionally suppressive. However, the suppressive effect of Vg1 + cells could also be converted to an enhancing effect if these cells were rendered activated. The balance of enhancing or inhibiting function of gd T cells is mainly determined by the proportion of the gd T cells that are activated versus those that are not activated.
Our results demonstrated that activation is a major factor in switching the enhancing and inhibitory functions of both the Vg1 + and the Vg4 + gd T subsets. The difference in activation requirements accounted for the selective dominance of a specific gd T subset. The net functional balance between the enhancing and inhibiting effects of gd T cells is mainly determined by the number of activated gd T cells and the proportion of activated versus nonactivated gd T cells.
Materials and Methods

Animals and reagents
Female C57BL/6 (B6) and TCR-d 2/2 mice on the B6 background, purchased from The Jackson Laboratory (Bar Harbor, ME), were housed and maintained in the animal facilities of the University of California, Los Angeles, and were used at 12-16 wk of age. The experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of California, Los Angeles (Protocol ARC#2014-029-03A). Recombinant murine IL-12, IL-23, and GM-CSF were purchased from R&D Systems (Minneapolis, MN). FITC-, PE-, or allophycocyaninconjugated mouse mAbs against mouse ab-TCR (clone H57-597), mouse gd-TCR Vg4 (UC3), mouse gd-TCR Vg1 (211), mouse gd-TCR (clone GL3), mouse IL-17, mouse IFN-g, mouse CD73, or mouse CD44 and isotype control Abs were all purchased from BioLegend (San Diego, CA).
Cell preparation
At day 13 postimmunization, CD3 + T cells were purified from the spleen or draining lymph nodes of B6 or TCR-d 2/2 mice immunized with peptide interphotoreceptor retinoid-binding protein (IRBP) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] (aa 1-20 of human IRBP; LifeTein, Hillsborough, NJ) by positive selection using a combination of FITC-conjugated anti-mouse CD3 Abs and anti-FITC Ab-coated Microbeads. Cells were then separated on an auto-MACS separator, according to the manufacturer's suggested protocol (Miltenyi Biotec, Auburn, CA).
The gd T cells were isolated from IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] -immunized mice at 13 d postimmunization, using a combination of FITC-conjugated anti-TCR-d Abs and anti-FITC Ab-coated Microbeads, followed by separation using an auto-MACS. To test the effect of activation by either cytokines or DCs, freshly prepared gd T cells from IRBP 1-20 -immunized B6 mice were cultured in cytokine-free medium for 5 d to generate the resting state because gd T cells freshly isolated from IRBP 1-20 -immunized mice are activated. The cells were then incubated for 48 h with a combination of IL-1, IL-7, and IL-23 (10 ng/ml of each), as described previously (35) , or for 48 h with bone marrow DCs (BMDCs) and anti-CD3 Abs.
EAU induction and evaluation
To induce EAU, B6 mice were injected s.c. at six spots at the tail base and on the flank with a total of 200 ml emulsion consisting of equal volumes of 150 mg peptide IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] in PBS and CFA (BD Biosciences, San Diego, CA), and i.p. with 200 ng pertussis toxin (Sigma-Aldrich, St. Louis, MO).
Assessment of Th17 responses
Responder TCR-ab + T cells (3 3 10 6 ) prepared from IRBP 1-20 -immunized TCR-d 2/2 mice were cocultured for 48 h with IRBP 1-20 (10 mg/ml) and irradiated spleen cells (2 3 10 6 per well) as APCs in a 12-well plate under Th17 polarized conditions (culture medium supplemented with 10 ng/ml IL-23), with or without the addition of gd T cells. IL-17 levels in the culture medium were then measured using ELISA kits (R&D Systems), and the number of Ag-specific T cells expressing IL-17 was determined by intracellular staining, followed by FACS analysis, as described below (35, 37) .
ELISA measurement of cytokine levels in serum and culture supernatants ELISA was used to measure cytokine (IL-1, IL-7, IL-12, IL-23, and IL-17) levels in the serum on day 13 postimmunization and in the 48-h culture supernatants of responder T cells isolated from immunized TCR-g 2/2 mice in the absence or presence of Vg1 or Vg4 cells.
Immunofluorescence flow cytometry for surface and cytoplasmic Ags
In vivo primed T cells were stimulated with the immunizing Ag and APCs for 5 d; then the T cells were separated using Ficoll gradient centrifugation and stimulated in vitro for 4 h with 50 ng/ml PMA, 1 mg/ml ionomycin, and 1 mg/ml brefeldin A (all from Sigma-Aldrich). Aliquots of cells (2 3 10 5 cells) were then fixed, permeabilized overnight with Cytofix/Cytoperm buffer (eBioscience, San Diego, CA), and intracellularly stained with PE-conjugated anti-mouse IFN-g Abs or FITC-labeled anti-mouse IL-17 Abs. Data collection and analysis were performed on a FACScalibur flow cytometer using CellQuest software.
Generation of BMDCs
BMDCs were generated by incubating bone marrow cells from B6 mice for 5 d in the presence of 10 ng/ml murine granulocyte rM-CSF (R&D Systems), as described previously (38) . To test the stimulating effect of these cells on gd T cells, the BMDCs were pretreated for 48 h with 100 ng/ml LPS (39).
CFSE assays
Purified ab-TCR + T cells from IRBP 1-20 -immunized TCR-d 2/2 mice were stained with CFSE (Sigma-Aldrich), as described previously (40) . Briefly, the cells were washed and suspended at 50 3 10 6 cells/ml in serum-free RPMI 1640 medium; cells were then incubated at 37˚C for 10 min with gentle shaking with a final concentration of 5 mM CFSE before being washed twice with, and suspended in, complete medium, stimulated with immunizing peptide in the presence of APCs, and analyzed by flow cytometry.
Measurement of adenosine receptor mRNA levels
Cytokine (IL-1, IL-7, and IL-23) receptor mRNA levels were determined by real-time PCR. Vg1 + and Vg4 + gd T cells were purified from IRBP 1-20 -immunized B6 mice by autoMACS separation. Total RNA was extracted from 2 3 10 5 cells using an RNA isolation kit (Invitrogen, Carlsbad, CA) and treated with DNase I (GE Healthcare, Piscataway, NJ); then 0.1 mg was reverse transcribed into cDNA using a Moloney murine leukemia virus reverse-transcription kit (Invitrogen) and tested in a Cyber Green real-time PCR assay. Levels of each cDNA were measured in triplicate, using GAPDH cDNA as reference. Each cDNA sample was amplified for the gene of interest. The concentration of the mRNA for the gene of interest was determined using the comparative threshold cycle number and normalized to that of the internal GAPDH control. Results were shown as 2 2OCt .
Statistical analyses
All experiments were repeated three to five times. Experimental groups typically consisted of six mice, and the figures show the data from a representative experiment. The statistical significance of differences between the values for different groups was examined using the MannWhitney U test.
Results
Vg4
+ cells gradually become the dominant gd cells in the spleen of immunized B6 mice Kinetic examination of the intensity of induced autoimmune responses and the appearance of Vg1 + and Vg4 + T cells in the spleen of immunized B6 mice demonstrated that the maximal responses to the immunizing Ag were constantly detected ∼13 d after immunization, ∼1 wk before clinical symptoms were detected. The Vg1 + gd T cells constitute approximately two-thirds of the total splenic gd T cells in naive mice, and in immunized mice until 6 d postimmunization, whereas the Vg4 + gd T cells constitute only one-third (Fig. 1A) . The non-Vg4 non-Vg1 cells are very few. These proportional numbers shifted dramatically, starting 6-7 d postimmunization. By 12 d postimmunization, the Vg1 + gd T cells had declined quickly to 11.2% of the total splenic gd T cells, whereas the Vg4 + gd T cells had increased to 86.5%, leading to a change in the ratio of Vg1:Vg4 from 7:3 to 1:8. Estimation of the absolute numbers of Vg1 and Vg4 cells showed, additionally, the absolute number of Vg1 + gd T cells remained largely unchanged, whereas that of the Vg4 + gd T cells increased 5-to 10-fold (Fig. 1B, 1C ).
+ cells in immunized B6 mice are activated, whereas the Vg1 + gd T cells remain nonactivated
We have assessed the activation status of Vg1 and Vg4 cells immediately after isolation from splenic T cells of naive or immunized mice. Fig. 2A (Fig. 2C) . In addition, a significant portion of the Vg4 + T cells, but not of the Vg1 + T cells, expressed IL-17, in the absence of additional in vitro stimulation (Fig. 2D) . We have previously reported that activated gd T cells have a strong enhancing effect on Th17 responses (30, 34, 35, 42 
IL-17
+ cells among the responder T cells were assessed by intracellular staining with IL-17 (Fig. 3A) . In addition, T cell supernatants were tested for IL-17 production by ELISA 48 h after stimulation (Fig. 3B) . Our results showed that the addition of a small number (2%) of Vg4 + cells strongly enhanced the Th17 response, whereas the addition of Vg1 + cells was ineffective or slightly suppressive (Fig. 3A, 3B) (Fig. 3C) , as examined by intracellular staining of the responder T cells, or by assessing cytokine production in 48 cultured supernatants by ELISA (data not shown). In addition, when the suppressive effect was tested, the Vg1 + cells, but not Vg4 + cells, that were freshly isolated from immunized mice showed greater suppressive effect, particularly when in the presence of exogenously added AMP (Fig. 3D) . 
cells in vitro
To determine whether different activation requirements were due to the biased activation of Vg4 + gd subset during autoimmune induction, we examined the serum cytokines that were increased in immunized mice and found IL-1, IL-23, and IL-7 increased significantly in the serum of immunized mice, as compared with that of naive mice (Fig. 4) . When separated Vg1
+ and Vg4 + gd T cells were exposed to a combination of IL-1, IL-23, and IL-7, only the Vg4 + , but not the Vg1 + , gd T cells were activated (Fig. 5A-C) . The stimulated Vg4 + T cells produced significantly increased amounts of IL-17 after exposure to either cytokines or anti-CD3 Ab (Fig. 5D) . The Vg1 + cells, in contrast, expressed increased levels of CD44 and CD25 only and downregulated CD73 after exposure to anti-CD3 Abs, but not to cytokines (Fig. 5A-C) . To determine the mechanism by which cytokines biasedly activated Vg4 + gd T cells, we have compared the cytokine receptor expression between Vg1 + and Vg4 + gd T cells. The new RT-PCR results (Fig. 5E) showed that Vg4 + , but not Vg1 + cells in immunized mice expressed increased amounts of IL-1R and IL-23R, even though expression of IL-7R was indistinguishable between the two cells.
Role of DC in biased Vg4
+ T cell activation
Our previous studies showed that DCs have a stimulating effect on gd T cells (36, 43, 44) , if pre-exposed to TLR ligands such as LPS (39, 43) . BMDCs were cultured from bone marrow cells of immunized mice in medium containing GM-CSF. To determine whether LPS-treated BMDCs stimulated Vg1 + and Vg4 + gd subsets, CD3 + responder T cells were isolated from the spleens of naive B6 mice, and the gated Vg1 + and Vg4 + gd cells were assessed for expression of CD25 and CD44 by FACS analysis, 2 d after coculture with BMDCs. Our results showed that the Vg4 + cells expressed greatly increased amounts of CD25 and CD44, whereas the Vg1 + did not (Fig. 6B compares to Fig. 6A ) after exposure to LPS-treated BMDCs. We have also examined whether direct cell-cell contact is mandatory for DCs to render a Vg4 + T cell activated. Vg1 + and Vg4 + cells were cultured in medium with supernatants of LPS-stimulated BMDCs (1:10 dilution) for 48 h, before assessment of gd T cell activation molecules, CD44 and CD25 (42) . The results showed that LPStreated BMDC supernatant has a strong stimulating effect on Vg4 + , but not on Vg1 + cells (Fig. 6C ). Cytokine test (Fig. 6D ) detected increased IL-17 production from Vg4 + , but not from Vg1 + cells after incubation with BMDCs.
Vg1
+ gd T cells' enhancing activity is increased, but suppressive activity is decreased after exposure to anti-CD3 mAb
To determine whether activation can convert the enhancing and suppressive effect of both Vg1 + and Vg4 + subsets, Vg1 + and Vg4 + T cells were assessed for their enhancing and inhibiting effects before or after exposure to anti-mouse CD3 mAb (34, 42) . The enhancing effect on Th17 response was assessed by testing the response of in vivo primed ab T cells stimulated with the immunizing Ag and APCs under Th17 polarized conditions (culture medium containing IL-23) and in the absence or presence of added gd T cells (Fig. 7A) . The enhancing effect was significantly augmented when Vg1 + or Vg4 + cells were added after anti-CD3 stimulation. As expected, the enhancing effect was minimal when nonactivated cells were added to responder T cells.
We previously reported that the inhibitory effect of gd T cells was better demonstrated if exogenous AMP was provided because nonactivated gd T cell expresses higher amounts of CD73, which more effectively degrades AMP to adenosine (42, 45, 46) . Activated gd T cells, in contrast, expressed decreased levels of CD73, which weakened their ability to convert AMP to adenosine (42) . Inhibition test used a CFSE assay, in which the responder ab T cells were prelabeled with CFSE before stimulation with the immunizing peptide and APCs (Fig. 7B) . Unlabeled Vg1 + and Vg4 + gd T cells, with or without prior anti-CD3 mAb stimulation, were added to responder cells at a ratio of gd:ab = 1:20. The results, assessed 7 d after in vitro stimulation, showed that, in the presence of AMP, both Vg1 + and Vg4 + resting cells showed a suppressive effect, whereas both Vg1 + and Vg4 + activated cells showed a significantly diminished suppressive activity. Importantly, the suppressive effect was partially neutralized by the CD73 inhibitor, the adenosine 59-(a,b-methylene)diphosphate (Fig. 7B) (47, 48) .
Discussion
Although a regulatory effect of gd T cells on adaptive immunity has been repeatedly observed (22, (26) (27) (28) , knowledge of how these cells regulate remains very limited, and the mechanisms by which they enhance an immune response in some cases (49-51) but inhibit it in others (16-18, 52) remain largely obscure. A better understanding of the mechanisms by which gd T cells regulate immune response should facilitate the development of gd T cellrelated therapeutic approaches. In a number of induced autoimmune diseases, including EAU (9, 11, 30, 53) , a prevailing activation of Vg4 + cells was observed; however, the mechanism of such a biased gd activation to disease pathogenesis remains unclear. The current study is aimed at determining the mechanism that causes the biased gd T cell activation and determining the factors that convert the enhancing and inhibiting effect of gd T cells. Previous studies have shown that the functional diversity of gd T cell subsets is correlated to distinct TCRs they express (21, 22, 54, 55) . Later studies also demonstrated that the enhancing and inhibiting activity of gd T cells could be converted by a pre-exposure of these cells to bacterial products (23, 25) . Furthermore, studies by our laboratory have demonstrated that activated gd T cells possessed a greatly + and Vg4 + cells was assessed before and after an exposure to cytokine or anti-CD3 Ab. Vg1 + and Vg4 + gd subsets were separated from immunized B6 mice 13 d postimmunization. They were exposed for 48 h in culture to a combination of IL-1, IL-23, and IL-7 (10 ng/ml) or anti-CD3 Ab (1 mg/ml). Expression of CD44 (A), CD73 (B), and CD25 (C) of Vg1 + and Vg4 + cells before and after cytokine or Ab stimulation was compared, after staining with + and Vg4 + cells were purified from splenocytes and drainage lymphocytes of immunized B6 mice by auto-MACs purification, using (PE)-conjugated anti-Vg1 or anti-Vg4 Abs and anti-PE Ab-conjugated magnetic beads. Quantitative PCR was performed with GAPDH as the internal reference. Results were represented as 2 2DCt . **p , 0.01; ns, not significant.
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) demonstrated milder Th17 response when induced for EAU as compared with wild-type B6 mice (30, 34) , and administration of gd T cells to TCR-d 2/2 mice before immunization greatly enhanced the disease susceptibility associated with an augmented Th17 response (34, 35, 43) . In vitro study also showed that the addition of a small number (2%) of gd T cells to responder ab T cells greatly enhanced their Th17 responses in vitro (30, 35, 41, 56) . Development of induced EAU in the EAU-prone B6 mouse is associated with an increased activation and dominance of Vg4 + gd T cells (30) . The contribution of these biased gd T cells to disease development remained unclear. In this study, we show that, in the preclinical phases of EAU, a vigorous activation and expansion of Vg4 + cells are caused by cytokines produced by activated myeloid cells. The Vg1
+ gd T cells are the poor responder cells of cytokines in this inflammatory environment. As a result, Vg4
+ cells are activated and become the dominant gd subset. Our results demonstrated that this dominance shift of gd subsets is due to the preferred activation requirements of the different gd subsets. We conclude that the appearance of a larger number of activated gd T cells, rather than the gd subset expressing a specific TCR segment, or the Vg4 + subset, is the major factor leading to disease progression. This assumption is supported by the evidence that Vg1 + cells also gained enhancing activity after being activated. We previously observed that administration of gd-specific Ab removed gd T cells more effectively in naive mice, whereas the gd T cells of immunized mice were more resistant to the depletion, because the activated gd T cells express decreased numbers of surface-expressed TCR that allowed them to escape removal by the injected Abs (31, 56) . Injection of gd-specific Ab may remove the non-or less activated gd T cell population more easily than activated cells. The outcome of this treatment will weaken the suppressive effect, shifting the balance from suppression toward The Journal of Immunology 7
http://www.jimmunol.org/ enhancement. Our results showing that the gd T subsets differed in activation requirements suggested that both Vg1 + and Vg4 + gd T cell subsets can either enhance or inhibit, depending on the disease-associated microenvironment that determines gd T cell activation. Such a prediction is supported by observations that Vg1 + gd T cells are dominantly activated in many different infectious disease models (57) (58) (59) (60) (61) (62) .
We found that cytokines (IL-1, IL-23, IL-7) that are stimulatory to Vg4 + gd T cells were mainly produced by myeloid rather than by T cells (data not shown). Indeed, cytokines in LPS-stimulated BMDC supernatants showed a strong stimulatory effect, indicating that DC activation and release of cytokines play a major role in gd activation in the early stage of induced autoimmune disease.
In studies clarifying the mechanism by which activated gd T cells gain increased enhancing activity, we have made efforts to identify molecules that contribute to such a functional switch. We were able to show that activated gd T cells express altered levels of IL-23R (35) , giving gd T cells a competitive ability to bind IL-23, which would abate subsequently initiated Th17 ab T cell responses that require IL-23 (35) . In recent studies (41, 42) , we also demonstrated that activated gd T cells express low levels of CD73 molecules, an ecto-enzyme that converts proinflammatory extracellular ATP to adenosine, which is suppressive for adaptive responses (63, 64) . Expression of low levels of CD73 causes activated gd T cells to convert less adenosine from extracellular ATP, which would predispose to stronger T cell responses. Such a hypothesis has been supported by the evidence that the suppressive effect of gd T cells is readily amplified if exogenous AMP, a precursor molecule of adenosine, is provided; and the suppressive effect is abolished in the presence of a CD73 inhibitor (41, 42) , indicating expression of different amounts of CD73 allows gd T cells to modulate their regulatory effect. Results in the current study further confirmed this hypothesis by showing that the Vg1 + cells in EAU-induced mice retained the ability to express higher amounts of CD73; thus, the inhibiting effect prevailed in the Vg1 + cells. Nevertheless, the enhancing activity prevailed when the function of the entire gd T cells is assessed, because the Vg1 + cells in immunized mice were greatly outnumbered by activated Vg4 + T cells. The fact that anti-CD3 mAb-activated Vg1 + gd T cells showed an increased enhancing effect, but a decreased suppressive activity, appeared to support the notion that activation status is an important factor balancing the enhancing and suppressive effects in the two gd T cell subsets.
In summary, our previous results demonstrated that activation switches the inhibitory and enhancing effect of gd T cell (34, 35, 42, 43 ). In the current study, we further demonstrate that the activation-induced functional change is not restricted to Vg4 + cells, but also applies to Vg1 + cells. An abundance of activated Vg4 + gd T cells shifts the enhancing and suppressing activities toward the former, leading to enhanced disease susceptibility. 
